|1.||Tahaghoghi-Hajghorbani, Sahar: 1 article (01/2015)|
|2.||Jalali, Seyed Amir: 1 article (01/2015)|
|3.||Masoumi, Elham: 1 article (01/2015)|
|4.||Jaafari, Mahmoud Reza: 1 article (01/2015)|
|5.||Ghaffari-Nazari, Haniyeh: 1 article (01/2015)|
|6.||Tavakkol-Afshari, Jalil: 1 article (01/2015)|
|7.||Monie, Archana: 1 article (01/2010)|
|8.||Wu, Chao-Yi: 1 article (01/2010)|
|9.||Wu, T-C: 1 article (01/2010)|
|10.||Pang, Xiaowu: 1 article (01/2010)|
01/01/2010 - "We observed that mice vaccinated with E7 peptide-based vaccine in combination with PADRE peptide and poly(I:C) generated better E7-specific CD8+ T cell immune responses as well as significantly improved therapeutic anti-tumor effects against TC-1 tumors compared to E7 peptide-based vaccine with either PADRE peptide or poly(I:C) alone. "
01/01/2015 - "The results show that vaccination with the multi-epitope long peptide in combination with the PADRE peptide and CpG-ODN induced expansion of subpopulations of CD4+ and CD8+ cells producing IFN-γ, the average tumor size in the vaccinated mice was less than that of the other groups, and tumor growth was inhibited in 40% of the mice in the vaccinated group. "
12/01/2009 - "Here, based on six copies of the B cell epitope GRP(18-27) in a linear alignment as an immunogen, we designed several anti-GRP DNA vaccines containing different combinations of immunoadjuvants, such as HSP65, tetanus toxoid(830-844) (T), pan HLA-DR-binding epitope (PADRE) (P), and mycobacterial HSP70(407-426) (M), on a backbone of pCR3.1 plasmid vector with eight 5'-GACGTT-3' CpG motifs and the VEGF183 signal peptide (VS). "
|2.||Protein Sorting Signals (Signal Peptide)
|4.||B-Lymphocyte Epitopes (B-Cell Epitope)
|5.||Immunologic Adjuvants (Immunologic Adjuvant)